HCA Healthcare (NYSE:HCA – Free Report) had its price objective lowered by Truist Financial from $546.00 to $535.00 in a research report sent to investors on Monday morning, Marketbeat reports. Truist Financial currently has a buy rating on the stock.
A number of other equities research analysts have also weighed in on HCA. UBS Group lifted their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. Sanford C. Bernstein set a $541.00 price objective on shares of HCA Healthcare in a report on Monday, February 9th. Wells Fargo & Company lifted their price objective on shares of HCA Healthcare from $452.00 to $481.00 and gave the company an “equal weight” rating in a report on Friday, January 30th. Barclays reduced their price target on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a report on Monday. Finally, KeyCorp set a $503.00 price target on shares of HCA Healthcare in a report on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $523.09.
View Our Latest Analysis on HCA
HCA Healthcare Trading Up 3.2%
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the previous year, the business earned $6.45 EPS. The company’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts forecast that HCA Healthcare will post 30.15 earnings per share for the current year.
HCA Healthcare Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s payout ratio is presently 10.99%.
Insider Activity
In other news, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the transaction, the executive vice president owned 8,853 shares of the company’s stock, valued at $4,721,924.61. The trade was a 16.06% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the transaction, the senior vice president directly owned 44,379 shares in the company, valued at approximately $22,411,395. The trade was a 8.27% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 15,214 shares of company stock worth $7,797,595 in the last quarter. 1.50% of the stock is currently owned by corporate insiders.
Institutional Trading of HCA Healthcare
Large investors have recently bought and sold shares of the stock. Sumitomo Life Insurance Co. grew its position in HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after buying an additional 20 shares during the last quarter. MJP Associates Inc. ADV increased its position in HCA Healthcare by 2.9% during the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after purchasing an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC increased its position in HCA Healthcare by 7.5% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after purchasing an additional 21 shares during the period. Anchyra Partners LLC increased its position in HCA Healthcare by 3.7% during the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after purchasing an additional 21 shares during the period. Finally, Sovran Advisors LLC increased its position in HCA Healthcare by 1.0% during the 3rd quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock worth $1,063,000 after purchasing an additional 22 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.
More HCA Healthcare News
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: Management reaffirmed FY2026 guidance and expects 2%–3% volume growth while acknowledging headwinds, which supports the company’s forward earnings outlook. HCA projects 2%-3% volume growth
- Positive Sentiment: HCA says improvements in its revenue‑cycle operations are boosting cash collections and helping offset rising denials/underpayments — a near‑term margin and cash‑flow positive. Revenue cycle paying dividends
- Positive Sentiment: Leadership hire: Cynthia Cifuentes‑Finkel will become SVP of Marketing & Corporate Affairs (effective June 8), adding senior marketing/communications capacity ahead of growth initiatives. HCA names new SVP
- Neutral Sentiment: Local operations: a new HCA Florida Gainesville hospital is preparing to open next month — incremental local growth but limited immediate impact on enterprise results. Gainesville hospital opening
- Neutral Sentiment: Market commentary pieces and index signals are discussing healthcare positioning; useful for macro context but not company‑specific catalysts. Market update
- Negative Sentiment: Multiple analysts reduced price targets and trimmed forecasts after Q1 results (despite an in‑line EPS), signaling more cautious near‑term sentiment. Firms lowering targets include Stephens, Oppenheimer, TD Cowen, Leerink, RBC and Truist. Analysts slash forecasts
- Negative Sentiment: Q1 dynamics: EPS roughly in‑line but seasonal volume softness, shifting payer mix and projected ACA/exchange pressures (company cites a $600M–$900M headwind range) are weighing on near‑term revenue and margin expectations. Q1 deep dive
- Negative Sentiment: Financing: HCA filed a proposed public offering of senior notes to raise proceeds for general corporate purposes (may include refinancing). New debt issuance could modestly pressure credit metrics depending on size and terms. Proposed senior notes offering
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Recommended Stories
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
